Abstract:
The invention relates to modified silica, substituted with a variety of substituents. There is provided a product termed primary hydroxyl silica where there are attached to the silica substituents bearing a single hydroxyl group. Furthermore there are provided a wide variety of derivatives of such hydroxy-silica, which are of value in affinity chromatography and for various other uses. The products combine the thermal and mechanical stability of the silica used as carrier with the useful properties of the substituents.
Abstract:
The invention relates to pharmaceutical compositions for use against protozoa. The compositions comprise particles in the micron-size range which are physiologically acceptable to humans and which can be ingested by protozoa. The particles, which can be of natural materials such as silica or the like, serve as carrirs of an effective anti-protozoal drug. A variety of anti-amebic drugs can be bound to such particles.
Abstract:
The invention relates to pharmaceutical compositions for use against protozoa. The compositions comprise particles in the micron-size range which are physiologically acceptable to humans and which can be ingested by protozoa. The particles, which can be of natural materials such as silica or the like, serve as carrirs of an effective anti-protozoal drug. A variety of anti-amebic drugs can be bound to such particles.
Abstract:
Described are complexes between a physiologically acceptable macromolecular carrier and an anti-tumor active platinum compound useful as anti-cancer drugs.
Abstract:
The invention relates to modified silica, substituted with a variety of substituents. There is provided a product termed primary hydroxyl silica where there are attached to the silica substituents bearing a single hydroxyl group. Furthermore there are provided a wide variety of derivatives of such hydroxy-silica, which are of value in affinity chromatography and for various other uses. The products combine the thermal and mechanical stability of the silica used as carrier with the useful properties of the substituents.
Abstract:
Described are complexes between a physiologically acceptable macromolecular carrier and an anti-tumor active platinum compound useful as anti-cancer drugs.